148 related articles for article (PubMed ID: 35036633)
1. Quantifying Systematic RBE-Weighted Dose Uncertainty Arising from Multiple Variable RBE Models in Organ at Risk.
Koh WYC; Tan HQ; Ng YY; Lin YH; Ang KW; Lew WS; Lee JCL; Park SY
Adv Radiat Oncol; 2022; 7(2):100844. PubMed ID: 35036633
[TBL] [Abstract][Full Text] [Related]
2. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
[TBL] [Abstract][Full Text] [Related]
3. The dirty and clean dose concept: Towards creating proton therapy treatment plans with a photon-like dose response.
Heuchel L; Hahn C; Ödén J; Traneus E; Wulff J; Timmermann B; Bäumer C; Lühr A
Med Phys; 2024 Jan; 51(1):622-636. PubMed ID: 37877574
[TBL] [Abstract][Full Text] [Related]
4. Clinical implementation in proton therapy of multi-field optimization by a hybrid method combining conventional PTV with robust optimization.
Tommasino F; Widesott L; Fracchiolla F; Lorentini S; Righetto R; Algranati C; Scifoni E; Dionisi F; Scartoni D; Amelio D; Cianchetti M; Schwarz M; Amichetti M; Farace P
Phys Med Biol; 2020 Feb; 65(4):045002. PubMed ID: 31851957
[TBL] [Abstract][Full Text] [Related]
5. The Role of Plan Robustness Evaluation in Comparing Protons and Photons Plans - An Application on IMPT and IMRT Plans in Skull Base Chordomas.
Noufal MP; Widesott L; Sharma SD; Righetto R; Cianchetti M; Schwarz M
J Med Phys; 2020; 45(4):206-214. PubMed ID: 33953495
[TBL] [Abstract][Full Text] [Related]
6. Preliminary evaluation of multifield and single-field optimization for the treatment planning of spot-scanning proton therapy of head and neck cancer.
Quan EM; Liu W; Wu R; Li Y; Frank SJ; Zhang X; Zhu XR; Mohan R
Med Phys; 2013 Aug; 40(8):081709. PubMed ID: 23927306
[TBL] [Abstract][Full Text] [Related]
7. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
[TBL] [Abstract][Full Text] [Related]
8. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
[TBL] [Abstract][Full Text] [Related]
9. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of dose-averaged linear energy transfer (LET
Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
[TBL] [Abstract][Full Text] [Related]
11. The Organ Sparing Potential of Different Biological Optimization Strategies in Proton Therapy.
Henjum H; Dahle TJ; Fjæra LF; Rørvik E; Pilskog S; Stokkevåg CH; Mairani A; Ytre-Hauge KS
Adv Radiat Oncol; 2021; 6(6):100776. PubMed ID: 34765804
[TBL] [Abstract][Full Text] [Related]
12. The impact of proton LET/RBE modeling and robustness analysis on base-of-skull and pediatric craniopharyngioma proton plans relative to VMAT.
Gutierrez A; Rompokos V; Li K; Gillies C; D'Souza D; Solda F; Fersht N; Chang YC; Royle G; Amos RA; Underwood T
Acta Oncol; 2019 Dec; 58(12):1765-1774. PubMed ID: 31429359
[No Abstract] [Full Text] [Related]
13. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
[TBL] [Abstract][Full Text] [Related]
14. Quantification of the uncertainties of a biological model and their impact on variable RBE proton treatment plan optimization.
Resch AF; Landry G; Kamp F; Cabal G; Belka C; Wilkens JJ; Parodi K; Dedes G
Phys Med; 2017 Apr; 36():91-102. PubMed ID: 28410691
[TBL] [Abstract][Full Text] [Related]
15. Energy layer optimization strategies for intensity-modulated proton therapy of lung cancer patients.
Jensen MF; Hoffmann L; Petersen JBB; Møller DS; Alber M
Med Phys; 2018 Oct; 45(10):4355-4363. PubMed ID: 30129041
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
17. Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?
Giantsoudi D; Adams J; MacDonald S; Paganetti H
Acta Oncol; 2018 Sep; 57(9):1259-1264. PubMed ID: 29726722
[TBL] [Abstract][Full Text] [Related]
18. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
[TBL] [Abstract][Full Text] [Related]
19. Reformulated McNamara RBE-weighted beam orientation optimization for intensity modulated proton therapy.
Ramesh P; Lyu Q; Gu W; Ruan D; Sheng K
Med Phys; 2022 Apr; 49(4):2136-2149. PubMed ID: 35181892
[TBL] [Abstract][Full Text] [Related]
20. Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.
Hirayama S; Matsuura T; Yasuda K; Takao S; Fujii T; Miyamoto N; Umegaki K; Shimizu S
J Appl Clin Med Phys; 2020 Apr; 21(4):42-50. PubMed ID: 32150329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
